Search results for "030211 gastroenterology & hepatology"

showing 10 items of 1275 documents

Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?

2017

Background In the absence of liver biopsy, the World Health Organization recommends non-invasive tests, such as aspartate aminotransferase to platelet ratio index and FIB-4, to assess liver fibrosis in patients with chronic hepatitis B. However, these tests are not well validated in sub-Saharan Africa. Recently, a new marker, gamma-glutamyl transpeptidase to platelet ratio, was found to be more accurate in an African setting, but this needs confirmation in other cohorts. Methods A treatment program for chronic hepatitis B was initiated in Addis Ababa, Ethiopia, in 2015. Non-invasive tests were compared with transient elastography (Fibroscan 402, Echosense, France) using the following thresh…

medicine.medical_specialtyCirrhosisViral Hepatitismedicine.disease_causeGastroenterology03 medical and health sciences0302 clinical medicineFibrosisInternal medicinemedicineGamma-glutamyltransferaseliver fibrosisHepatitis B virusHepatologyReceiver operating characteristicmedicine.diagnostic_testbiologybusiness.industrynon‐invasive testsmedicine.disease030220 oncology & carcinogenesisLiver biopsyPredictive value of testsbiology.proteinOriginal Article030211 gastroenterology & hepatologybusinessTransient elastographyhepatitis B virussub‐Saharan AfricaLiver International
researchProduct

Longterm Survival After Liver Transplantation for Autoimmune Hepatitis : Results From the European Liver Transplant Registry

2020

The aim of this study was to analyze longterm patient and graft survival after liver transplantation for autoimmune hepatitis (AIH-LT) from the prospective multicenter European Liver Transplant Registry. Patient and liver graft survival between 1998 and 2017 were analyzed. Patients after AIH-LT (n = 2515) were compared with patients receiving LT for primary biliary cholangitis (PBC-LT; n = 3733), primary sclerosing cholangitis (PSC-LT; n = 5155), and alcohol-related cirrhosis (AC-LT; n = 19,567). After AIH-LT, patient survival was 79.4%, 70.8%, and 60.3% and graft survival was 73.2%, 63.4%, and 50.9% after 5, 10, and 15 years of follow-up. Overall patient survival was similar to patients af…

medicine.medical_specialtyCirrhosismedicine.medical_treatmentCholangitis SclerosingMedizinAutoimmune hepatitis030230 surgeryLiver transplantationGastroenterologyPrimary sclerosing cholangitis03 medical and health sciences0302 clinical medicineInternal medicinemedicineLiving DonorsHumansProspective StudiesRegistriesTransplantationHepatologybusiness.industryLiver Cirrhosis BiliaryHazard ratioPatient survivalmedicine.diseasedigestive system diseasesLiver TransplantationHepatitis AutoimmuneIncreased risk030211 gastroenterology & hepatologySurgeryGraft survivalbusiness
researchProduct

Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain

2020

Background Delta hepatitis is a rare infection with an aggressive disease course. For almost three decades, however, there have been no epidemiological studies in our traditionally endemic area. Aim To investigate the prevalence of delta hepatitis in a sample of patients with chronic hepatitis B virus (HBV) infection followed at a Hepatology Unit in Valencia, Spain. Methods Retrospective evaluation of anti-hepatitis D virus-immunoglobulin G seroprevalence among patients with chronic HBV infection (n = 605) followed at a reference Hepatology Unit in Spain. Results The prevalence of anti-hepatitis D virus-immunoglobulin G among HBV-infected patients was 11.5%: Male (63%) and median age of 52 …

medicine.medical_specialtyCirrhosismedicine.medical_treatmentImmigrationLiver transplantation03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusEpidemiologymedicineSeroprevalenceViral hepatitisLiver transplantationHepatologybusiness.industryDelta hepatitisCase Control StudyHepatologymedicine.diseaseCirrhosis030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyValenciaViral hepatitisbusinessWorld Journal of Hepatology
researchProduct

A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease

2021

Patients with nonalcoholic fatty liver disease (NAFLD) may show mild cognitive impairment (MCI). The neurological functions affected remain unclear. The aims were to: (1) Characterize the neuropsychological alterations in NAFLD patients; (2) assess the prevalence of impairment of neurological functions evaluated; (3) develop a new score for sensitive and rapid MCI detection in NAFLD; (4) assess differences in MCI features between patients with nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH); and (5) compare neuropsychological alterations in NAFLD patients with cirrhotic patients with MCI. Fifty-nine NAFLD patients and 53 controls performed psychometric tests assessin…

medicine.medical_specialtyCirrhosisneurological impairmentpsychometric scoreGastroenterologybehavioral disciplines and activitiesdigestive systemArticle03 medical and health sciences0302 clinical medicineInternal medicineNAFLDNonalcoholic fatty liver diseasemedicineMemory spanHepatic encephalopathyPsychomotor learningbusiness.industryFatty liverRNeuropsychologyNASHnutritional and metabolic diseasesGeneral Medicinemedicine.diseasepsychometric score; NAFLD; NAFL; NASH; neurological impairmentdigestive system diseasesNAFLMedicine030211 gastroenterology & hepatologybusiness030217 neurology & neurosurgeryStroop effectJournal of Clinical Medicine
researchProduct

Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy

2020

Minimal hepatic encephalopathy (MHE) is associated with mild cognitive impairment and frailty. This study aims to identify cognitive and motor differences in cirrhotic patients with and without MHE, and the correlations between motor signs and cognitive performance. Gait, balance, hand strength and motor speed performance were evaluated in 66 cirrhotic patients (38 without and 28 with MHE, according to the Psychometric Hepatic Encephalopathy Score (PHES). Cognitive performance was measured with the Mini-Mental State Examination, Verbal Fluency Test, Aprendizaje Verbal España-Complutense Test (TAVEC), Wechsler Adult Intelligence Scale III, Hamilton Depression and Anxiety Rating Scale and Fun…

medicine.medical_specialtyCirrosi hepàticalcsh:Medicineminimal hepatic encephalopathyAprenentatge motorAudiologyArticlecognitive assessment03 medical and health sciences0302 clinical medicineRating scaleHand strengthmedicineVerbal fluency testEffects of sleep deprivation on cognitive performanceHepatic encephalopathyminimal hepatic encephalopathy; biomechanics measurements; cognitive assessmentbiomechanics measurements cognitive assessment minimal hepatic encephalopathybusiness.industrylcsh:RWechsler Adult Intelligence ScaleCognitionGeneral Medicinemedicine.diseaseAnxiety030211 gastroenterology & hepatologymedicine.symptombusinessAprenentatge Aptitud per a l' Testshuman activities030217 neurology & neurosurgerybiomechanics measurements
researchProduct

Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe

2018

Abstract: Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely silent pandemic, its elimination is made possible through the availability of the new antiviral drugs and the implementation of prevention practices. On 17 February 2016, the Hepatitis B & C Public Policy Association held the first EU HCV Policy Summit in Brussels. This summit was an historic event as it was the first high-level conference focusing on the elimination of HCV at the European Union level. The …

medicine.medical_specialtyCivil societyEconomic growthMedizinPublic policyHepacivirusAntiviral AgentsPatient advocacy03 medical and health sciences0302 clinical medicineVirologyPolitical sciencePandemicPrevalencemedicineHumansmedia_common.cataloged_instanceEuropean Union030212 general & internal medicineDisease EradicationEuropean unionmedia_commongeographySummitgeography.geographical_feature_categoryHepatologyPublic healthmedicine.diseaseHepatitis CEuropeInfectious DiseasesHCVEpidemiological Monitoring030211 gastroenterology & hepatologyHuman medicineViral hepatitisJournal of Viral Hepatitis
researchProduct

Surgical anatomy of D3 lymphadenectomy in right colon cancer, gastrocolic trunk of Henle and surgical trunk of Gillot - a video vignette

2018

medicine.medical_specialtyColonColorectal cancermedicine.medical_treatment03 medical and health sciences0302 clinical medicineSurgical anatomyColon surgeryCadaverCadavermedicineHumansColectomyColectomybusiness.industryGastroenterologymedicine.diseaseTrunkSurgeryVignette030220 oncology & carcinogenesisGastrocolic trunkColonic NeoplasmsLymph Node Excision030211 gastroenterology & hepatologyAnatomic LandmarksbusinessMesocolon
researchProduct

Virtual chromoendoscopy with iSCAN as an alternative method to dye-spray chromoendoscopy for dysplasia detection in long-standing colonic inflammator…

2021

Patients with long-standing colonic inflammatory bowel disease (cIBD) are at increased risk of developing colorectal cancer (CRC). Dye-spray chromoendoscopy (DCE) with targeted biopsies is the preferred technique for surveillance of dysplasia. Virtual chromoendoscopy (VCE) are arising to improve detection rates and adherence to surveillance guidelines, although its role is not yet well defined. The purpose of this study is to assess the effectiveness of VCE with iSCAN as an alternative method for dysplasia detection in cIBD.Retrospective case-control study with 191 patients included, 98 in the DCE (Indigo carmine) group and 93 in the VCE (iSCAN, twin-mode 1-3) group. The dysplasia detection…

medicine.medical_specialtyColorectal cancerColonoscopyInflammatory bowel diseaseGastroenterologyChromoendoscopy03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansColoring Agentsskin and connective tissue diseasesEarly Detection of CancerRetrospective StudiesAlternative methodsmedicine.diagnostic_testbusiness.industryGastroenterologyCase-control studyColonoscopyInflammatory Bowel Diseasesmedicine.diseasedigestive system diseasesIncreased riskDysplasiaCase-Control Studies030220 oncology & carcinogenesisColitis Ulcerative030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessScandinavian Journal of Gastroenterology
researchProduct

Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-sided Colon Cancer

2020

OBJECTIVE The aim of this prospective clinical study is to compare short-term outcome of laparoscopic right hemicolectomy using the Complete Mesocolic Excision (CME group) with patients who underwent conventional right-sided colonic resection (NCME group). SUMMARY BACKGROUND DATA Although CME with central vascular ligation in laparoscopic right hemicolectomy is associated with a significant decrease in local recurrence rates and improvements in cancer-related 5-year survival, there may be additional risks associated with this technique because of increased surgical complications. As a result, there is controversy surrounding its use. METHODS In this randomized controlled trial, several prim…

medicine.medical_specialtyColorectal cancerMEDLINEAnastomosislaw.inventionClinical study03 medical and health sciencesText mining0302 clinical medicineRandomized controlled triallawHumansMedicinelaparoscopic colonic resectionbusiness.industryGeneral surgerymedicine.diseaselaparoscopic surgeryTerm (time)SurgerySettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisColonic Neoplasmsright colon cancerFeasibility StudiesOperative timeLaparoscopy030211 gastroenterology & hepatologySurgerycomplete mesocolic excisionLymphSpecimen lengthbusinessLigationMesocolonAnnals of Surgery
researchProduct

A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.

2021

Abstract Aim Management paradigms for tumours from the sigmoid colon to the lower rectum vary significantly. The upper rectum (UR) represents the transition point both anatomically and in treatment protocols. Above the UR is clearly defined and managed as colon cancer and below is managed as rectal cancer. This study compares outcomes between sigmoid, rectosigmoid and UR tumours to establish if differences exist in operative and oncological outcomes. Methods Electronic databases were searched for published studies with comparative data on peri-operative and oncological outcome for upper rectal and sigmoid/rectosigmoid (SRS) tumours treated without neoadjuvant radiation. The search adhered t…

medicine.medical_specialtyColorectal cancermedicine.medical_treatmentHealth StatusRectumAnastomotic LeakAnastomosis03 medical and health sciences0302 clinical medicinemedicineHumansNeoplasm MetastasisIntraoperative ComplicationsLymph nodeNeoplasm Stagingbusiness.industryRectal NeoplasmsRectumSigmoid colonCancerGeneral Medicinemedicine.diseaseRadiation therapySurvival RateSigmoid Neoplasmsmedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisMeta-analysisLymphatic Metastasis030211 gastroenterology & hepatologySurgeryRadiologyNeoplasm GradingNeoplasm Recurrence LocalbusinessEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct